Select Page

BioIQ Helps Employers Comply with New ACA Wellness Requirements

Health Improvement Technology Company Helps Companies Engage Employees in a Non-Discriminatory Manner to Measure Individual and Population Health.

BioIQ announced that its health-improvement technology platform helps employers comply with the final regulations of the Patient Protection and Affordable Care Act (ACA). Leveraging the BioIQ platform, organizations throughout the United States can increase wellness program participation, avoid discrimination, and meet stated health and wellness goals. BioIQ has published a free guide to complying with these regulations. It explains how to create progressive wellness programs that measure health improvement on both an individual and population level.

BioIQ offers a comprehensive set of products and services to help employers achieve and verify compliance with ACA wellness requirements. For example, BioIQ Dimensions offers several health-screening methods for gathering biometric data from employees and dependents to enforce nondiscrimination. BioIQ program participants who are unable to take a blood test or meet stated health standards due to a medical condition are allowed to request an alternative or a waiver. BioIQ Axis connects individuals to specific interventions based on their identified risks and needs. BioIQ Ecosystem funnels participants into an array of complementary health, wellness, and disease-management solutions to improve their health. This patented “closed-loop” wellness platform helps all participants to earn rewards by meeting agreed-upon milestones and outcomes. Specific risk-factors trigger targeted interventions. Secure personal health dashboard enable participants to track their progress and allow administrators to manage participation, outcomes, rewards and incentives, all while protecting personal health information as per HIPAA requirements.

“To comply with the ACA mandates, employers need to engage the entire population, carefully track the results, and provide direct interventions to help participants achieve healthy outcomes and meet personal wellness goals,” said Justin Bellante, CEO of BioIQ. “Thousands of employers rely on BioQ to comply with the regulatory landscape as they measure the health of their workforce and set reasonable goals for improvement. BioIQ’s targeted, metrics-based approach invariably leads to reduced medical costs, more productive employees, and improved health outcomes—all while fulfilling ACA and IRS requirements.”

In the ACA final regulations, the U.S. Departments of Treasury, Labor, and Health and Human Services explained how wellness programs should be structured to comply with the non-discrimination requirements. Outcomes-based programs (also called health-contingent wellness programs) not only require participation; they also require individuals to attain or maintain specific health outcomes as measured by biometric screening or a health risk assessment. Corporate wellness programs must track individual results related to each requirement and allow employees to take additional steps to achieve the stated outcomes to obtain wellness incentives or rewards. These programs must also offer reasonable alternatives for people who have a specific condition that precludes them from achieving the outcome, so that the individual can earn the incentives via other agreed-upon means, as validated by a recent Internal Revenue Service bulletin.


About BioIQ

BioIQ is a health improvement technology company that has implemented the industry’s first integrated, customizable and measurable approach to optimizing investments in corporate health and wellness programs. The company’s unique health screening platform, ecosystem of health improvement tools, and proven methodology for obtaining quantifiable wellness insights are serving beneficiaries across the United States. BioIQ works with some of the largest employers and health companies in the nation and has launched over 2,500 successful health improvement programs since its inception in 2005.

Press Contact: David Baum
Director of Communications, BioIQ